JPH02292208A - Skin cosmetic composition - Google Patents
Skin cosmetic compositionInfo
- Publication number
- JPH02292208A JPH02292208A JP1115796A JP11579689A JPH02292208A JP H02292208 A JPH02292208 A JP H02292208A JP 1115796 A JP1115796 A JP 1115796A JP 11579689 A JP11579689 A JP 11579689A JP H02292208 A JPH02292208 A JP H02292208A
- Authority
- JP
- Japan
- Prior art keywords
- leaves
- cosmetic composition
- skin cosmetic
- extract
- skin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 30
- 239000002537 cosmetic Substances 0.000 title claims abstract description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 26
- 239000000284 extract Substances 0.000 claims abstract description 21
- 229930183009 gymnemic acid Natural products 0.000 claims abstract description 21
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 12
- 229940126902 Phlorizin Drugs 0.000 claims abstract description 12
- IOUVKUPGCMBWBT-UHFFFAOYSA-N phloridzosid Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 IOUVKUPGCMBWBT-UHFFFAOYSA-N 0.000 claims abstract description 12
- IOUVKUPGCMBWBT-GHRYLNIYSA-N phlorizin Chemical compound O[C@@H]1[C@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 IOUVKUPGCMBWBT-GHRYLNIYSA-N 0.000 claims abstract description 12
- 235000019139 phlorizin Nutrition 0.000 claims abstract description 12
- 235000011430 Malus pumila Nutrition 0.000 claims abstract description 11
- 235000015103 Malus silvestris Nutrition 0.000 claims abstract description 11
- 239000001689 FEMA 4674 Substances 0.000 claims abstract description 9
- 229930182647 Trilobatin Natural products 0.000 claims abstract description 9
- GSTCPEBQYSOEHV-QNDFHXLGSA-N trilobatin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C=C1O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 GSTCPEBQYSOEHV-QNDFHXLGSA-N 0.000 claims abstract description 9
- 244000141359 Malus pumila Species 0.000 claims abstract description 7
- 244000144730 Amygdalus persica Species 0.000 claims abstract description 6
- 244000126002 Ziziphus vulgaris Species 0.000 claims abstract description 6
- 239000002904 solvent Substances 0.000 claims abstract description 5
- 235000006040 Prunus persica var persica Nutrition 0.000 claims abstract description 4
- 235000014443 Pyrus communis Nutrition 0.000 claims abstract description 4
- 235000008529 Ziziphus vulgaris Nutrition 0.000 claims abstract description 4
- 241000255972 Pieris <butterfly> Species 0.000 claims abstract description 3
- 241001316753 Pieris japonica Species 0.000 claims abstract description 3
- 235000004789 Rosa xanthina Nutrition 0.000 claims abstract description 3
- 241000220222 Rosaceae Species 0.000 claims abstract description 3
- 241000543392 Symplocos Species 0.000 claims abstract 4
- 240000001987 Pyrus communis Species 0.000 claims abstract 2
- VGEREEWJJVICBM-UHFFFAOYSA-N phloretin Chemical compound C1=CC(O)=CC=C1CCC(=O)C1=C(O)C=C(O)C=C1O VGEREEWJJVICBM-UHFFFAOYSA-N 0.000 claims description 18
- ZWTDXYUDJYDHJR-UHFFFAOYSA-N (E)-1-(2,4-dihydroxyphenyl)-3-(2,4-dihydroxyphenyl)-2-propen-1-one Natural products OC1=CC(O)=CC=C1C=CC(=O)C1=CC=C(O)C=C1O ZWTDXYUDJYDHJR-UHFFFAOYSA-N 0.000 claims description 9
- YQHMWTPYORBCMF-UHFFFAOYSA-N Naringenin chalcone Natural products C1=CC(O)=CC=C1C=CC(=O)C1=C(O)C=C(O)C=C1O YQHMWTPYORBCMF-UHFFFAOYSA-N 0.000 claims description 9
- 241000220225 Malus Species 0.000 claims description 7
- -1 acebotin Chemical compound 0.000 claims description 7
- 241000208253 Gymnema sylvestre Species 0.000 claims description 5
- 244000228391 Salvia elegans Species 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 28
- 206010014970 Ephelides Diseases 0.000 abstract description 15
- 208000003351 Melanosis Diseases 0.000 abstract description 15
- 241001247821 Ziziphus Species 0.000 abstract description 10
- 241000208251 Gymnema Species 0.000 abstract description 8
- 208000001840 Dandruff Diseases 0.000 abstract description 6
- 208000003251 Pruritus Diseases 0.000 abstract description 6
- 230000007803 itching Effects 0.000 abstract description 6
- 238000011282 treatment Methods 0.000 abstract description 5
- 239000004480 active ingredient Substances 0.000 abstract description 4
- 235000019693 cherries Nutrition 0.000 abstract description 3
- 210000004761 scalp Anatomy 0.000 abstract description 2
- NMHMNPHRMNGLLB-UHFFFAOYSA-N phloretic acid Chemical compound OC(=O)CCC1=CC=C(O)C=C1 NMHMNPHRMNGLLB-UHFFFAOYSA-N 0.000 abstract 2
- PQCIBORQLVRFMR-OCVXTVMPSA-N 1-[2-hydroxy-4-methoxy-6-[(2r,3s,4r,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]-3-(4-hydroxyphenyl)propan-1-one Chemical compound O([C@@H]1[C@H]([C@H](O)[C@@H](O)[C@H](CO)O1)O)C1=CC(OC)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 PQCIBORQLVRFMR-OCVXTVMPSA-N 0.000 abstract 1
- 241000167854 Bourreria succulenta Species 0.000 abstract 1
- BVGNIAWOQSCZOZ-UHFFFAOYSA-N N-methyl-zizyphine-B Natural products C1=CNC(=O)C2CCCN2C(=O)C2N(C(=O)C(NC(=O)C(C(C)CC)N(C)C)C(C)CC)CCC2OC2=CC=C(OC)C1=C2 BVGNIAWOQSCZOZ-UHFFFAOYSA-N 0.000 abstract 1
- 241000220317 Rosa Species 0.000 abstract 1
- 229930185929 Zizyphine Natural products 0.000 abstract 1
- IEXIUZSNKNXTJS-ZGJYDULXSA-N asebotin Natural products COc1cc(O)c(cc1O[C@@H]2O[C@H](CO)[C@@H](O)[C@@H](O)[C@H]2O)C(=O)CCc3ccc(O)cc3 IEXIUZSNKNXTJS-ZGJYDULXSA-N 0.000 abstract 1
- DZAUWHJDUNRCTF-UHFFFAOYSA-N dihydrocaffeic acid Natural products OC(=O)CCC1=CC=C(O)C(O)=C1 DZAUWHJDUNRCTF-UHFFFAOYSA-N 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 17
- 239000007788 liquid Substances 0.000 description 14
- 238000002360 preparation method Methods 0.000 description 12
- 210000004027 cell Anatomy 0.000 description 11
- 239000006071 cream Substances 0.000 description 11
- 208000024891 symptom Diseases 0.000 description 10
- 230000006872 improvement Effects 0.000 description 9
- 239000006210 lotion Substances 0.000 description 9
- 230000002829 reductive effect Effects 0.000 description 9
- 239000002453 shampoo Substances 0.000 description 9
- 241000196324 Embryophyta Species 0.000 description 8
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 8
- 230000002087 whitening effect Effects 0.000 description 8
- 239000000287 crude extract Substances 0.000 description 7
- 238000011156 evaluation Methods 0.000 description 7
- 239000008213 purified water Substances 0.000 description 7
- 238000009472 formulation Methods 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 238000010521 absorption reaction Methods 0.000 description 5
- 239000006286 aqueous extract Substances 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- 208000001382 Experimental Melanoma Diseases 0.000 description 3
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 3
- 239000004472 Lysine Substances 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 241000220324 Pyrus Species 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 239000012141 concentrate Substances 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 210000001035 gastrointestinal tract Anatomy 0.000 description 3
- 230000008099 melanin synthesis Effects 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 230000002335 preservative effect Effects 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 235000011446 Amygdalus persica Nutrition 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- 108010024636 Glutathione Proteins 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 2
- 241001290151 Prunus avium subsp. avium Species 0.000 description 2
- 235000018992 Prunus glandulosa Nutrition 0.000 description 2
- 240000001619 Prunus glandulosa Species 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 102000003425 Tyrosinase Human genes 0.000 description 2
- 108060008724 Tyrosinase Proteins 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 229940069521 aloe extract Drugs 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 229960003180 glutathione Drugs 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 210000002826 placenta Anatomy 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- 235000019605 sweet taste sensations Nutrition 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- WFIYPADYPQQLNN-UHFFFAOYSA-N 2-[2-(4-bromopyrazol-1-yl)ethyl]isoindole-1,3-dione Chemical compound C1=C(Br)C=NN1CCN1C(=O)C2=CC=CC=C2C1=O WFIYPADYPQQLNN-UHFFFAOYSA-N 0.000 description 1
- YJLUBHOZZTYQIP-UHFFFAOYSA-N 2-[5-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]-1,3,4-oxadiazol-2-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1=NN=C(O1)CC(=O)N1CC2=C(CC1)NN=N2 YJLUBHOZZTYQIP-UHFFFAOYSA-N 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 241000208327 Apocynaceae Species 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 241000288673 Chiroptera Species 0.000 description 1
- OIFBSDVPJOWBCH-UHFFFAOYSA-N Diethyl carbonate Chemical compound CCOC(=O)OCC OIFBSDVPJOWBCH-UHFFFAOYSA-N 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 1
- AOMUHOFOVNGZAN-UHFFFAOYSA-N N,N-bis(2-hydroxyethyl)dodecanamide Chemical compound CCCCCCCCCCCC(=O)N(CCO)CCO AOMUHOFOVNGZAN-UHFFFAOYSA-N 0.000 description 1
- VCUFZILGIRCDQQ-KRWDZBQOSA-N N-[[(5S)-2-oxo-3-(2-oxo-3H-1,3-benzoxazol-6-yl)-1,3-oxazolidin-5-yl]methyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C1O[C@H](CN1C1=CC2=C(NC(O2)=O)C=C1)CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F VCUFZILGIRCDQQ-KRWDZBQOSA-N 0.000 description 1
- 208000012641 Pigmentation disease Diseases 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 241000219100 Rhamnaceae Species 0.000 description 1
- 241001303601 Rosacea Species 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 235000021016 apples Nutrition 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- QGGZBXOADPVUPN-UHFFFAOYSA-N dihydrochalcone Chemical class C=1C=CC=CC=1C(=O)CCC1=CC=CC=C1 QGGZBXOADPVUPN-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 229940126534 drug product Drugs 0.000 description 1
- 229940124274 edetate disodium Drugs 0.000 description 1
- 210000002472 endoplasmic reticulum Anatomy 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000000887 face Anatomy 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 210000001061 forehead Anatomy 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 229940050410 gluconate Drugs 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940031957 lauric acid diethanolamide Drugs 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- ZBJWWKFMHOAPNS-UHFFFAOYSA-N loretin Chemical class C1=CN=C2C(O)=C(I)C=C(S(O)(=O)=O)C2=C1 ZBJWWKFMHOAPNS-UHFFFAOYSA-N 0.000 description 1
- 229950010248 loretin Drugs 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 239000000401 methanolic extract Substances 0.000 description 1
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 125000001117 oleyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])/C([H])=C([H])\C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 201000004700 rosacea Diseases 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 230000003637 steroidlike Effects 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Abstract
Description
【発明の詳細な説明】
(産業上の利用分野)
この発明は皮膚用化粧料組成物に係り、その目的は人の
皮膚の正常化に有効な新しい皮膚用化粧料組成物(医薬
部外品たる薬用化粧品及び医薬品たる外用皮膚用剤を含
む。以下同じ)であって特にシミ、ソバカス等の予防又
は治療に有効な皮膚用化粧料組成物であって、ギムネマ
の葉、ナツメの葉、バラ科の植物の幹皮、根皮又は葉或
いはアセビ、アマシバの葉の成分等を有効成分として含
有する皮膚用化粧料組成物に関する。Detailed Description of the Invention (Field of Industrial Application) This invention relates to a skin cosmetic composition, and its purpose is to create a new skin cosmetic composition (quasi-drug product) that is effective in normalizing human skin. A skin cosmetic composition that is particularly effective for the prevention or treatment of age spots, freckles, etc., including medicinal cosmetics and external skin preparations that are pharmaceuticals. The present invention relates to a skin cosmetic composition containing as an active ingredient ingredients such as the stem bark, root bark or leaves of plants of the same family, or the leaves of Asebifolia and Amashiba.
(従来の技術)
従来から、皮膚化粧料として、シミ、ソバカス等の予防
又は治療に、種々の薬剤を配合することが提案されてい
るが、有効性、安全性あるいは安定性の面から、十分満
足できるものは少ない。(Prior Art) Conventionally, it has been proposed to incorporate various drugs into skin cosmetics to prevent or treat age spots, freckles, etc. There are few things that are satisfying.
現在迄ハイドロキノン及びその誘導体がこれらの予防又
は治療に生体試験で幾分効果を発揮することが知られて
いる。Until now, it has been known that hydroquinone and its derivatives are somewhat effective in preventing or treating these diseases in biological tests.
しかしこれは副作用として時々再生不可能な色素沈着を
起こし現在使用されていない。However, this sometimes causes irreproducible pigmentation as a side effect and is currently not used.
従って現在ではより作用の緩和なビタミンC又はその誘
導体、アロエエキス、胎盤エキス、グルタチオン等がこ
の目的に使用されているが、まだ満足できるものではな
い。Therefore, at present, vitamin C or its derivatives, aloe extract, placenta extract, glutathione, etc., which have milder effects, are used for this purpose, but these are still not satisfactory.
即ち、これらは作用が極めて弱い上に、ビタミンC類、
胎盤エキス、グルタチオンは製剤後の安定性に問題があ
り、アロエエキスは経時的に褐変する等の欠点があった
。In other words, these have extremely weak effects, and they also have vitamin C,
Placenta extract and glutathione had problems with stability after preparation, and aloe extract had drawbacks such as browning over time.
(問題点を解決するための手段)
この発明は、シミ、ソバカス等の皮膚に有効な皮膚用化
粧料組成物を開発するべく鋭意研究を行な9た結果・ギ
ムネマ(Gymnema sylvestre R.B
r)の葉、ナツメ(Zixyphus jujuba
M.v. i.R.)の葉又はリンゴ(Malus p
umila M.v.d.s. ) 、サクラ(Pru
nus glandulosa T.) 、ナシ(Py
rus serotinaRehd. ) 、又はモモ
(Prunus persica Batsch)の幹
皮又は根皮、又はリンゴ(Malus pumilaM
. v. d. s. )の葉、アセビ(Pieris
japonica D.Don)又はアマシバ(Sy
mplocos microcalyx)の葉のうち少
なくとも1種以上を含有することを特徴とする皮膚用化
粧料組成物を完成し、シミ、ソバカス等の予防又は治療
に対して極めて効果的な作用を有することを発見した。(Means for Solving the Problems) This invention was developed as a result of intensive research to develop a skin cosmetic composition that is effective against spots, freckles, etc. Gymnema sylvestre R.B.
r) leaves, jujube (Zixyphus jujuba)
M. v. i. R. ) leaves or apple (Malus p.
umila m. v. d. s. ), Sakura (Pru
nus glandulosa T. ), pear (Py
rus serotinaRehd. ), or stem bark or root bark of peach (Prunus persica Batsch), or apple (Malus pumila M).
.. v. d. s. ) leaves, Pieris
japonica D. Don) or Amashiba (Sy)
We have completed a skin cosmetic composition characterized by containing at least one type of leaves of Mplocos microcalyx, and discovered that it has an extremely effective effect on the prevention or treatment of age spots, freckles, etc. did.
(発明の構成)
この発明で使用するギムネマ( Gymnemasyl
vesLre R.Br)とはインド原産のガガイモ科
の植物ギムネマ−シルベスタ(Gymnema syl
vestreR.Br. )であり、インドから中国に
及ぶ熱帯から亜熱帯に分布植生している。(Structure of the invention) Gymnemasyl used in this invention
vesLre R. Br) is Gymnema sylvesta, a plant of the Asclepiadaceae family native to India.
vestreR. Br. ) and is a vegetation distributed in the tropics to subtropics from India to China.
インドでは約2,000年前から、糖尿病治療薬として
使用されてきたことが、アユル・べ工一ダー等の医学書
にも記載されている。In India, it has been used as a diabetes treatment for about 2,000 years, as described in medical texts by Ayur Beko-Ida and others.
ギムネマ(Gymnema sylvestre R.
Br)の特徴的な性質としては、このものが甘味を抑制
する性質を有していることであり、やはり2,000年
も以前よりインドではよく知られた事実であった。Gymnema (Gymnema sylvestre R.
A characteristic property of Br) is that it has the property of suppressing sweetness, a fact that has been well known in India for over 2,000 years.
19世紀末にはその主成分がギムネマ酸という物質であ
るということが判明している。At the end of the 19th century, it was discovered that its main component was a substance called gymnemic acid.
ギムネマ酸は種々の酸によりアシル化されたヘキサオキ
シーオレアネン(トリテルペン)のグルコン酸配糖体で
あるサボニンであり、アシル化の酸の種類と位置の違い
により多くの同族体が存在することが知られている。Gymnemic acid is sabonin, a gluconate glycoside of hexaoxyoleanene (triterpene) that has been acylated with various acids, and many homologs exist due to differences in the type and position of the acylated acid. Are known.
またナツメとはクロウメモドキ科植物、ナツメ(Ziz
yphus jujuba M.v.i.R.)であり
、その種子は生薬大棗として急迫症状の緩解を主治とし
て漢方薬で多用されている。Also, jujube is a plant of the buckthorn family, jujube (Ziz).
yphus jujuba M. v. i. R. ), and its seeds are widely used in Chinese medicine as the herbal medicine Dajuju to relieve acute symptoms.
このナツメ(Zizyphus jujuba M.v
.i.R.)の葉にもギムネマ酸と同様に甘味抑制効果
を有する物質が存在しており、その主成分はステロイド
系のサボニンであるジィジィフィンであることが知られ
ている。This jujube (Zizyphus jujuba M.v.
.. i. R. ) leaves also contain a substance that has a sweet taste-inhibiting effect similar to gymnemic acid, and its main component is known to be zizyfin, a steroidal sabonin.
またバラ科( Rosacea I)植物、殊にリンゴ
(Malus pumila M.v. i.R.)、
サクラ( Prunusglandulosa T.)
、ナシ(Pyrus serotinaRehd.)
、又はモモ(Prunus persica Bats
ch )の幹皮、根皮更にはリンゴの葉には、腸管から
糖の吸収を抑制する物質が存在すると言われ、その主成
分はジヒドロカルコンの誘導体であるフロリジン(Ph
lorizin )又はフロレチン(phloreLi
n)であることが知られている。Also, Rosaceae (Rosacea I) plants, especially apple (Malus pumila M.v.i.R.),
Sakura (Prunus glandulosa T.)
, Pear (Pyrus serotinaRehd.)
, or peach (Prunus persica Bats)
It is said that there is a substance that suppresses the absorption of sugar from the intestinal tract in the stem bark, root bark, and even in the leaves of apples.The main component is phlorizin (Ph), a derivative of dihydrochalcone.
lorizin) or phloretin (phloreLi)
n) is known.
このフロリジン、フロレチンの同族体であるアセボチン
、トリロバチンを含有するアセビ(Pieris ja
ponica D.Don)、アマシバ(Symp l
ocosmicrocalyx)の葉もこの発明では有
効に使用できる。しかし、これらは従来は専ら経口的に
使用されるのみで、皮膚用化粧料組成物等の外用剤とし
て使用された例は見当たらない。Acebi (Pieris ja
ponica D. Don), Amashiba (Symp l
ocosmicrocalyx leaves can also be effectively used in this invention. However, these have conventionally been used exclusively orally, and there have been no examples of their use as external preparations such as skin cosmetic compositions.
これらの植物由来の物質を、皮膚用化粧料組成物に含有
せしめることによって、シミ、ソバカスの予防又は治療
に有効で安全な新規の素材を提供することを、この発明
者等らは一連の研究の過程で発見しこの発明を完成した
。The inventors have conducted a series of studies to provide a new material that is effective and safe for preventing or treating age spots and freckles by incorporating these plant-derived substances into skin cosmetic compositions. He discovered this during the process and completed this invention.
これらの植物から皮膚用化粧料組成物を調製するには、
幹皮、根皮又は葉を乾燥してあるいは乾燥せずにそのま
ま使用することも可能であるが、繊維等の不溶固形物が
多量に含有されているので、葉を搾汗した液または溶媒
抽出液もし《はそれらの濃縮物もより有効に使用できる
。To prepare skin cosmetic compositions from these plants,
It is possible to use the stem bark, root bark, or leaves as they are, either dried or without drying, but since they contain a large amount of insoluble solids such as fibers, it is possible to use the leaves after sweating or solvent extraction. If liquids are used, their concentrates can also be used more effectively.
搾汁液の場合には、有効成分が残査中に多量に残存する
ことがあるので、より好ましくは適当な溶媒で抽出して
使用する。In the case of squeezed juice, since a large amount of active ingredients may remain in the residue, it is more preferable to use it after extraction with an appropriate solvent.
使用する溶媒は、植物葉からシミ、ソバカス等に対して
予防又は治癲効果を有する成分か効果的に抽出され得る
溶媒であれば、特に限定されないが、より好ましくは、
水又はエタノールもしくはそれらの混液である。The solvent to be used is not particularly limited as long as it can effectively extract components having preventive or therapeutic effects against spots, freckles, etc. from plant leaves, but more preferably,
Water or ethanol or a mixture thereof.
さらには、腸管からの糖吸収物質であるギムネマ酸、ジ
ィジィフィン、フロリジン、フロレチン、アセボチン、
トリロバチン等をより高濃度に含有するように調整又は
加工されたものも使用され得る。Furthermore, glucose absorption substances from the intestinal tract, such as gymnemic acid, dizyfin, phlorizin, phloretin, acebotin,
Those that have been adjusted or processed to contain trilobatin or the like at a higher concentration may also be used.
勿論、ギムネマ酸、ジィジィフィン、7口リジン、フロ
レチン、アセボチン、トリロバチンを単離精製して使用
して皮膚用化粧料組成物を製造できるのは当然のことで
ある。Of course, it is a matter of course that gymnemic acid, zydyfin, heptad lysine, phloretin, acebotine, and trilobatin can be isolated and purified and used to produce a skin cosmetic composition.
こうして得られたものを、化粧料の配合原料として通常
の化粧水、乳液、クリーム等の化粧料形態に配合して調
製することができる。The product obtained in this way can be blended into ordinary cosmetic forms such as lotions, milky lotions, creams, etc. as raw materials for cosmetic preparations.
こうして得られた皮膚用化粧料組成物は、シミ、ソバカ
ス等の予防又は治療に対して極めて脊効に作用し、生き
生きとした皮膚に蘇生させることが判明した。It has been found that the skin cosmetic composition thus obtained has an extremely effective effect on the prevention or treatment of age spots, freckles, etc., and revitalizes the skin with vigor.
この作用機序についてはまだあきらかではなく、現在鋭
意研究中であるが、この発明者らは次のように推定して
いる。Although this mechanism of action is not yet clear and is currently under intensive research, the inventors estimate as follows.
即ち、これらの植物のシミ、ソバヵス等の予防又は治療
に対する効果は、これらの持っている甘味抑制効果或い
は腸管からの糖吸収抑制効果とパラレルな関係がある。That is, the effects of these plants on preventing or treating age spots, freckles, etc. have a parallel relationship with their sweet taste suppressing effects or their sugar absorption suppressing effects from the intestinal tract.
このことから、糖吸収抑制物質、即ちギムネマ酸、ジィ
ジィフィン等は、皮膚のメラニン色素産生細胞において
も糖の細胞内への取り込みが抑制されるものと考えられ
る。一方、メラニン色素産生細胞内においては、メラニ
ン生成に関与するチロシナーゼは、粗面小胞のリポソー
ムで生成され、次いで、ゴルジ器官関連小胞体で糖鎖の
修飾を受けて活性化されることが知られている。以上の
点から、ギムネマ酸、ジィジィフィン、7口リジン、フ
ロレチン等は、メラニン産生細胞内への糖の吸収も同様
に抑制するものと考えられる。結果として、メラニン産
生細胞内では糖の不足を来し、糖鎖の修飾によるチロシ
ナーゼの活性化が抑制されるものと考えられる。またこ
れらの物質は、シミ、ソバヵスの予防又は治療に対する
効果以外にも、肌あれ、ニキビ、頭皮のフケ、カユミ等
に対しても、優れた効果を持つことも併せて研究中に見
い出した。From this, it is thought that sugar absorption inhibitors, ie, gymnemic acid, zizyfin, etc., suppress the uptake of sugar into cells even in melanin pigment-producing cells of the skin. On the other hand, it is known that in melanin pigment-producing cells, tyrosinase, which is involved in melanin production, is produced in liposomes of rough vesicles, and is then activated by modification of sugar chains in the endoplasmic reticulum associated with the Golgi organ. It is being From the above points, it is thought that gymnemic acid, zydyfin, heptad lysine, phloretin, and the like similarly suppress the absorption of sugar into melanin-producing cells. As a result, there is a shortage of sugar in melanin-producing cells, and it is thought that activation of tyrosinase due to modification of sugar chains is suppressed. In addition, it was discovered during research that these substances not only have an effect on preventing or treating age spots and freckles, but also have excellent effects on rough skin, acne, scalp dandruff, itching, and the like.
特に、肌あれに対する効果等に関しては、ギムネマ酸、
ジィジィフィン等の精製品よりも、粗抽出品の方が効果
が高い傾向がある。このことは、肌あれ等に対する効果
は、ギムネマ酸、ジィジィフィン、フロリジン、フロレ
チン、アセボチン、トリロバチン等の存在のみに帰属さ
せることは困難であるが、何れにしてもギムネマの葉又
はナツメの葉の中には、その他に多数の未知化合物が含
有されており、それらが相加的または相乗的に作用して
効果を発揮するものと考えられる。従って、皮膚用化粧
料組成物への使用に当たっては、目的によっては必ずし
も有効成分を単離して使用する必要はないし、またその
方が好ましい場合もある。In particular, regarding effects on rough skin, gymnemic acid,
Crude extracts tend to be more effective than refined products such as Jijifin. This means that it is difficult to attribute the effect on rough skin etc. solely to the presence of gymnemic acid, dizyfin, phlorizin, phloretin, acebotin, trilobatin, etc., but in any case, the effects of gymnema leaves or jujube leaves It contains many other unknown compounds, and it is thought that they act additively or synergistically to exert their effects. Therefore, when used in skin cosmetic compositions, it is not always necessary to isolate the active ingredient and use it, depending on the purpose, and it may be preferable in some cases.
(実施例及び実験例)
以下この発明について実施例及び実験例をもとに詳しく
説明する。(Examples and Experimental Examples) The present invention will be described in detail below based on Examples and Experimental Examples.
実施例 l
(ギムネマの葉の水性粗抽出液の調整)ギムネマ・シル
ベスタ(インド産)の乾燥した葉200gを60℃の温
水中に約5時間浸して濾過し、これを数回繰り返した。Example 1 (Preparation of crude aqueous extract of Gymnema leaves) 200 g of dried leaves of Gymnema sylvestre (produced in India) were soaked in warm water at 60° C. for about 5 hours and filtered, and this process was repeated several times.
得られた温水抽出液液を合わせて減圧濃縮し、再度濾過
して粗抽出液1.000ccを得た。The resulting hot water extracts were combined, concentrated under reduced pressure, and filtered again to obtain 1.000 cc of crude extract.
実施例 2
(ナツメの葉の水性粗抽出液の調整)
ナツメの葉を温風乾燥した後、その200gを60゜C
の温水中に約5時間浸して濾過し、これを数回繰り返し
た。得られた温水抽出液を合わせて減圧濃縮し、再度濾
過して粗抽出液1. OOOccを得た。Example 2 (Preparation of aqueous crude extract of jujube leaves) After drying jujube leaves with hot air, 200g of them were heated at 60°C.
The sample was soaked in warm water for about 5 hours and filtered, and this process was repeated several times. The obtained warm water extracts were combined and concentrated under reduced pressure, and filtered again to obtain crude extract 1. OOOcc was obtained.
実施例 3
(サクラの幹皮の水性粗抽出液の調整)乾燥したサクラ
の幹皮200gを60℃の温水中に約5時間浸して濾過
し、これを数回繰り返した。得られた温水抽出液を合わ
せて減圧濃縮し、再度濾過して粗抽出液1, 000c
cを得た。Example 3 (Preparation of aqueous crude extract of cherry trunk skin) 200 g of dried cherry trunk skin was soaked in warm water at 60° C. for about 5 hours and filtered, and this process was repeated several times. The obtained warm water extracts were combined and concentrated under reduced pressure, and filtered again to obtain 1,000 c of crude extract.
I got c.
実施例 4
(リンゴの葉200gを60℃の温水中に約5時間浸し
て濾過し、これを数回繰り返した。得られた温水抽出液
を合わせて減圧a縮し、再度濾過して粗抽出液1,OO
Occを得た。Example 4 (200 g of apple leaves was soaked in hot water at 60°C for about 5 hours and filtered, and this was repeated several times. The resulting hot water extracts were combined and condensed under reduced pressure, and filtered again to obtain a crude extraction. Liquid 1,OO
Got Occ.
実施例 5
(ギムネマの葉より、粗ギムネマ酸の調整)ギムネマの
乾燥した葉200gを60℃の温水中に約5時間浸し、
これを濾過して水抽出液を得た。これを数回繰り返した
。得られた温水抽出液2N硫酸でpH3に調整し、生じ
た沈澱物を15, OOOrpmで20分間遠沈して集
め、水でよく洗浄した後、エタノールで数回抽出を行な
った。エタノール抽出液を減圧濃縮し、その2倍量のア
セトンを加えたのち遠沈した。上清部を減圧下で濃縮乾
固し、それに炭酸ジエチルを加えて沸点下で数回抽出を
繰り返した。その後抽出液を濃縮し、冷後析出する粗ギ
ムネマ酸を集め乾燥した。粗ギムネマ酸1.4gを得た
。Example 5 (Preparation of crude gymnemic acid from gymnema leaves) Soak 200 g of dried gymnema leaves in warm water at 60°C for about 5 hours.
This was filtered to obtain an aqueous extract. This was repeated several times. The resulting hot water extract was adjusted to pH 3 with 2N sulfuric acid, and the resulting precipitate was collected by centrifugation at 15.00 rpm for 20 minutes, thoroughly washed with water, and then extracted several times with ethanol. The ethanol extract was concentrated under reduced pressure, and twice the amount of acetone was added thereto, followed by centrifugation. The supernatant was concentrated to dryness under reduced pressure, diethyl carbonate was added thereto, and extraction was repeated several times at boiling point. Thereafter, the extract was concentrated, and after cooling, the precipitated crude gymnemic acid was collected and dried. 1.4 g of crude gymnemic acid was obtained.
実施例 6
(ナツメの葉より粗ジィジィフィンの調整)乾燥したナ
ツメの葉200gを60℃の温水中に約5時間浸し、こ
れを濾過して水抽出液を得た。これを数回繰り返した。Example 6 (Preparation of crude Jijifin from jujube leaves) 200 g of dried jujube leaves were immersed in warm water at 60°C for about 5 hours, and filtered to obtain a water extract. This was repeated several times.
得られた温水抽出液を減圧下で濃縮乾固し、メタノール
で数回抽出を行った。The obtained hot water extract was concentrated to dryness under reduced pressure, and extracted several times with methanol.
メタノール抽出液を減圧下に1縮乾固し、これを蒸留水
に溶解してセファデックスG−10(ファルマシア社)
のカラムに通し、十分量の蒸留水で溶出した。この溶出
液を減圧濃縮した後、クロロホルム・エタノール混液で
数回抽出し、このものを1縮乾燥して粗シイジイフィン
0. 9gを得た。The methanol extract was condensed to dryness under reduced pressure, and this was dissolved in distilled water to obtain Sephadex G-10 (Pharmacia).
column and eluted with a sufficient amount of distilled water. After concentrating this eluate under reduced pressure, it was extracted several times with a mixture of chloroform and ethanol, and this product was condensed and dried to give a crude ciidifin with a concentration of 0.5%. 9g was obtained.
実験例 1
(メラニン生成抑制試験)
牛胎児血清lO%を含有するイーグルMEM培地4.
0ccに、試料液0. 1cc及びB−16メラノーマ
細胞tol5を含む培養液0. 1ccを加え、5%C
O 2空気下37℃で5日間培養する。この間に培地
交換を1回行った。5日間培養後の細胞を遠沈管に集め
、B−16メラノーマ細胞の白色化の程度を肉眼的に観
察した。但し試料液は、実施例1,2.3及び4の試料
についてはそれぞれ10倍希釈液、100倍希釈液とし
、実施例5及び6の試料についてはそれぞれ0.1mg
/cc, 0.01mg/ccとし、フロリジン及びフ
ロレチン(シグマ社製)はそれぞれ0.01mg/cc
, 0.001mg/ccとした。なおコントロールと
して精製水を使用した。Experimental Example 1 (Melanin production suppression test) Eagle MEM medium containing 10% fetal bovine serum4.
Add 0.0cc of sample liquid to 0.0cc. 1 cc and culture solution containing B-16 melanoma cells tol5. Add 1cc, 5%C
Incubate for 5 days at 37°C under O2 air. During this time, the medium was replaced once. After culturing for 5 days, the cells were collected in a centrifuge tube, and the degree of whitening of the B-16 melanoma cells was visually observed. However, the sample liquids were 10 times diluted and 100 times diluted for the samples of Examples 1, 2.3 and 4, respectively, and 0.1 mg for the samples of Examples 5 and 6, respectively.
/cc, 0.01mg/cc, and phlorizin and phloretin (manufactured by Sigma) were each 0.01mg/cc.
, 0.001 mg/cc. Note that purified water was used as a control.
いずれの場合も細胞はよく増殖し、白色化の肉眼的所見
は次の通りであった。In all cases, the cells proliferated well, and the macroscopic findings of whitening were as follows.
実施例lの調整液
lO倍希釈液
100倍希釈液
実施例2の調整液
lO倍希釈液
100倍希釈液
実施例3の調整液
10倍希釈液
100倍希釈液
実施例4の調整液
lO倍希釈液
100倍希釈液
実施例5の粗ギムネマ酸
0. 1mg/cc液
0.01 mg/cc液
実施例6のジィジィフィン
0. 1mg/cc液
+++
+
++
+++
++
+
+ +
+
++
+
O、Of mg/cc液
フロリジン
0.01 mg/cc液
0. 001mg/cc液
フロレチン
0.01 mg/cc液
0. OO1mg/cc液
コントロール
+++:白色化大
++:白色化普通
+:僅かに白色化
:白色化せず
+
+++
+ +
++
実施例 7
(実施例5で得られた粗ギヌネマ酸およびフロジンを含
有する化粧水の処方例)
処方 (1) (2)重量
% 重量%
粗ギムネマ酸
フロリジン
0.2
0. 05
エタノール 3.0 3.0
プロピレングリコール 4.5 4.5
グリセリン 0.5 0.5パ
ラオキシ安息香酸メチル 0.2 0.2パ
ラオキシ安息香酸エチル 0.02 0.0
2精製水 適量 適量上記
処方にて化粧水を調整した。Adjustment solution of Example 1 10 times diluted solution 100 times diluted solution Adjustment solution of Example 2 10 times diluted solution 100 times diluted solution Adjustment solution of Example 3 10 times diluted solution 100 times diluted solution Adjustment solution of Example 4 10 times Diluted solution 100 times diluted solution Example 5 crude gymnemic acid 0. 1 mg/cc liquid 0.01 mg/cc liquid Jizy Fin 0.01 mg/cc liquid Example 6 1 mg/cc liquid +++ + ++ +++ ++ + + + + + ++ + O, Of mg/cc liquid Phlorizin 0.01 mg/cc liquid 0. 001mg/cc liquid Phloretin 0.01 mg/cc liquid 0. OO1mg/cc liquid control +++: Large whitening ++: Whitening normal +: Slight whitening: No whitening + +++ + + ++ Example 7 (Containing the crude gynunemic acid and flozin obtained in Example 5) Prescription example of lotion) Prescription (1) (2) Weight% Weight% Crude gymnemic acid phlorizin 0.2 0. 05 Ethanol 3.0 3.0
Propylene glycol 4.5 4.5
Glycerin 0.5 0.5 Methyl p-oxybenzoate 0.2 0.2 Ethyl p-oxybenzoate 0.02 0.0
2 Purified water Appropriate amount Appropriate amount A lotion was prepared according to the above recipe.
実験例 2
(粗ギムネマ酸及びフロリジンを含有する皮膚用化粧料
組成物の効果)
8種類の化粧水を次の通り調整し、シミ、ソバカスに対
する効果を試験した。Experimental Example 2 (Effects of skin cosmetic compositions containing crude gymnemic acid and phlorizin) Eight types of lotions were prepared as follows, and their effects on age spots and freckles were tested.
処方a−dは実施例7の処方の粗ギムネマ酸の配合量を
次の通りとした。For formulations a to d, the amount of crude gymnemic acid in the formulation of Example 7 was as follows.
処方 a O.01重量%
処方 b 0.1 重量%
処方 c1、0 重量%
処方 d 2.0 重量%
処方e−hは実施例7の処方のフロリジンの配合量を次
の通りとした。Prescription a O. 01% by weight Prescription b 0.1% by weight Prescription c1, 0% by weight Prescription d 2.0% by weight For formulations e-h, the amount of phlorizin in the formulation of Example 7 was as follows.
処方 e O.005重量%
処方 f O.05 重量%処方 g
o.5 重量%
処方 h i.o 重量%
評価方法及び結果は次の通りである。Prescription e O. 005% by weight Prescription f O. 05 Weight% prescription g
o. 5% by weight Formula h i. o Weight % The evaluation method and results are as follows.
(1)被験者
シ ミ:シミの認められる女子45名(33才〜61
才)
ソバ力ス:ソバカスな認められる女子36名(17才〜
52才)
(2)試験方法
各症状について、被験者を9群に分け、8群に毎日朝夕
2回、温湯で石鹸洗顔後に化粧水を塗らせ、28日後及
び56日後にその改善効果を評価した。残りの1群は対
照とした。(1) Subjects with stains: 45 women with stains (33 to 61 years old)
Age) Freckles: 36 girls who are recognized as having freckles (from 17 years old)
(52 years old) (2) Test method For each symptom, subjects were divided into 9 groups, and the 8 groups were asked to apply lotion twice a day in the morning and evening after washing their faces with soap and warm water, and the improvement effect was evaluated 28 and 56 days later. . The remaining group served as a control.
(3)評価 シ ミ 1:色もかなり濃く境界もはっきりしている。(3) Evaluation Shi Mi 1: The color is quite dark and the border is clear.
2:色はそれ程濃くはないが境界はかなりはつきりして
いる。2: The color is not very dark, but the border is quite sharp.
3:色も極めて薄く境界もはっきりしない。3: The color is extremely pale and the border is not clear.
4:シミの症状は認められない。4: No stain symptoms observed.
ソバカス
l:黒色を帯びた斑点が頬に広がっており、時には額ま
で及んでいる。Freckles L: Blackish spots spread across the cheeks, sometimes extending to the forehead.
2:茶褐色〜灰色を帯びた斑点が頬に広がっている。2: Brown to grayish spots are spreading on the cheeks.
3:薄い茶褐色を帯びた斑点が頬に認められるが目立つ
程ではない。3: Light brown spots are observed on the cheeks, but they are not noticeable.
4:ソバカスの症状は認められない。4: No symptoms of freckles observed.
この症状の区分に従い次のように評価した。The symptoms were evaluated as follows according to the classification of symptoms.
有 効:症状が1から3.4に、及び2から4に改善
されたもの。Effective: Symptoms improved from 1 to 3.4 and from 2 to 4.
やや有効二症状が1から2に、2から3に及び3から4
に改善されたもの。Moderately effective 2 symptoms from 1 to 2, from 2 to 3, and from 3 to 4
improved on.
無 効:症状に殆ど変化がないかまたは悪化したもの
。Ineffective: There is little change in symptoms or symptoms have worsened.
評価結果を第1表及び第2表に示した。結果から明らか
なように、実施例1で得られた水性粗抽出液を含有する
化粧水は、何れもコントロールに比し優れた効果を有し
ている。The evaluation results are shown in Tables 1 and 2. As is clear from the results, all of the lotions containing the aqueous crude extract obtained in Example 1 have superior effects compared to the control.
第
表
(以下余白)
ギムネマ酸又は7口リジンを含有する化粧水の28日後
における評価結果粗ギムネマ酸又はフロリジンを含有す
るイ断の56日後における評価結果実施例 8
(実施例1,2.3及び4で得られた水性抽出液を含有
するクリームの調整)
処方 重量%ステアリン酸
2.0ステアリルアルコ
ール 6.0スクワラン
60還元ラノリン
2.0才クチルドデカノール
6.0ボリオキシエチレンセチル
エーテル(20E.O) 4,0親油型
モノステアリン酸グリセリン 1.5防腐剤
0.3実施例1,2.3又
は4の抽出液
のlO倍濃縮液 IO,0
香料 微量精製水
残部上記処方で上方に
よりクリームを調整した。Table (blank below) Evaluation results of lotion containing gymnemic acid or 7-mouth lysine after 28 days Evaluation results of lotion containing crude gymnemic acid or phlorizin after 56 days Example 8 (Example 1, 2.3 and Preparation of cream containing the aqueous extract obtained in 4) Formula Weight % Stearic acid 2.0 Stearyl alcohol 6.0 Squalane
60 reduction lanolin
2.0 year old cutyldodecanol
6.0 Polyoxyethylene cetyl ether (20E.O) 4.0 Lipophilic glycerin monostearate 1.5 Preservative
0.3 IO times concentrated solution of the extract of Example 1, 2.3 or 4 IO,0 Fragrance Micro-purified water
The rest of the cream was prepared according to the above recipe.
実施例 9(実施例1又は4で得られた水性抽出液を
含有する乳液の調整)
処方 重量%スクワラン
5.0ワセリン
2. 0セスキオレイン酸ソ
ルビタン 0. 8ポリオキシエチレンオ
レイル
工−テル(20E.O.) 1.2プロピシング
リコール 5.0エタノール
3.0カルボキシビニルボリマー
(1%水溶液) 18.0
水酸化カリウム 0. 1実
施例l又は4の抽出液のlO倍
濃縮液 10.0
防腐剤 0.3香料
微量精製水
残部上記処方で常法により乳液を
調整した。Example 9 (Preparation of emulsion containing the aqueous extract obtained in Example 1 or 4) Formula Weight % squalane
5.0 Vaseline
2. 0 Sorbitan sesquioleate 0. 8 Polyoxyethylene oleyl (20E.O.) 1.2 Propisine glycol 5.0 Ethanol
3.0 Carboxy vinyl polymer (1% aqueous solution) 18.0 Potassium hydroxide 0. 10 times concentrated solution of the extract of Example 1 or 4 10.0 Preservative 0.3 Flavor
micro purified water
The rest of the emulsion was prepared according to the above-mentioned formula in a conventional manner.
実施例 lO
(実施例1で得られた水性抽出液を含有するシャンプー
の調整)
処方 重量%実施例lの抽
出液の10倍濃縮液 10.0ボリオキシエチレン
ラウリルエーレル
硫酸ナトリウム(2E.0.) 8.5ラウリルジ
メリルアミノ
硫酸ベタイン 5,0
1,3−ブチレングリコール 4. 0ラ
ウリン酸ジエタノールアミド 2.0エデト酸
二ナトリウム 0. 1防腐剤
適量香料
適量精製水
残部上記処方で常法によりシャンプーを調
整した。Example 1O (Preparation of shampoo containing the aqueous extract obtained in Example 1) Formulation Weight % 10-fold concentrate of the extract of Example 1 10.0 Sodium polyoxyethylene lauryl ether sulfate (2E.0 .) 8.5 lauryl dimerylaminosulfate betaine 5,0 1,3-butylene glycol 4. 0 Lauric acid diethanolamide 2.0 Edetate disodium 0. 1 preservative
Appropriate amount of fragrance
Appropriate amount of purified water
The rest of the shampoo was prepared using the above formulation in a conventional manner.
実験例 3
(実施例8で得たクリームの効果)
実施例8で得たクリームのうち、実施例1の抽出液のl
O倍濃縮液を使用したクリームについて次の通り試験し
た。Experimental Example 3 (Effect of the cream obtained in Example 8) Of the cream obtained in Example 8, 1 of the extract of Example 1
A cream using an O-fold concentrate was tested as follows.
シミを有する被験者15名(女子24才〜57才)に、
実施例8のクリームを、他の15名(女子31才〜59
才)には比較例のクリームを毎日朝夕2回顔面に5週間
塗布し、シミの改善効果について実験例2の評価基準に
より試験した。同時に、肌あれ改善効果、しっとり感に
ついて実験例2の評価基準により試験した。同時に、肌
あれ改善効果、しっとり感についても改善度の程度によ
り有効無効の判定を行った。但し、比較例のクリームは
実施例8で使用した抽出液のかわりに精製水を使用した
。15 subjects (females 24 to 57 years old) with age spots.
The cream of Example 8 was applied to 15 other people (females 31 to 59 years old).
The cream of Comparative Example was applied to the face twice a day in the morning and evening for 5 weeks, and the age spot improvement effect was tested according to the evaluation criteria of Experimental Example 2. At the same time, the rough skin improving effect and moist feeling were tested according to the evaluation criteria of Experimental Example 2. At the same time, effectiveness or ineffectiveness was determined based on the degree of improvement regarding rough skin improvement effect and moisturizing feeling. However, in the cream of the comparative example, purified water was used instead of the extract used in Example 8.
実施例8のクリーム
(シミ改善効果)
有効 9/l5
やや有効 2/l5
無効 4/l5
(肌あれ改善効果)
有効 7/lO
無効 3/lO
(しっとり感)
有効 9/10
無効 1/1 0
比較例のクリーム
(シミ改善効果)
有効 1/l 5
やや有効 5/l5
無効 9/l5
(肌あれ改善効果)
有効 3/lO
無効 7/lO
(しっとり感)
有効 4/lO
無効 6/l0
実験例 4
(実施例lOで得られたシャンプー使用試験)フケ、カ
ユミの多い被験者10名(男子17〜48才)に実施例
10のシャンプーを、他のIO名(男子22〜 51才
)に比較例のシャンプーを週3回、1箇月にわたって使
用し、髪のしっとり感とフケ、カユミの改善について試
験した。Cream of Example 8 (stain improvement effect) Effective 9/l5 Slightly effective 2/l5 Ineffective 4/l5 (Skin improvement effect) Effective 7/lO Ineffective 3/lO (Moist feeling) Effective 9/10 Ineffective 1/1 0 Comparative cream (stain improvement effect) Effective 1/l 5 Slightly effective 5/l5 Ineffective 9/l5 (Skin improvement effect) Effective 3/lO Ineffective 7/lO (Moist feeling) Effective 4/lO Ineffective 6/l0 Experiment Example 4 (Test using the shampoo obtained in Example 1O) The shampoo of Example 10 was compared to 10 test subjects (males 17 to 48 years old) with a lot of dandruff and itching to other IO subjects (males 22 to 51 years old) The shampoo in this example was used three times a week for one month, and tested for improvement in moisturized hair, dandruff, and itching.
但し、比較例のシャンプーは実施例10のシャンプーの
抽出液のがわりに精製水を使用した。However, the shampoo of Comparative Example used purified water instead of the extract of the shampoo of Example 10.
実施例5のシャンプー 比較例のシャンプー(フケ・
カユミ) (フケ・カユミ)有効 7/1
0 有効 2/1o無効 3/10
無効 8/1 0実験例 5
(7ロレチン誘導体のメラニン生成抑制試験)調整液の
種類
アセボチン(asebot in) 0. O
IX液トリロバチン(trilobatin) 0
.01!% 液両者についてB−16メラノーマ細胞の
白色化の程度を観察したところ、細胞はよく増殖し、白
色化の肉眼的所見は次の通りであった。Shampoo of Example 5 Shampoo of Comparative Example (dandruff/
Itching) (dandruff and itching) Effective 7/1
0 valid 2/1o invalid 3/10
Ineffective 8/1 0 Experimental Example 5 (Melanin production inhibition test of 7 loretin derivatives) Type of adjustment solution Acebot in 0. O
IX liquid trilobatin (trilobatin) 0
.. 01! When the degree of whitening of B-16 melanoma cells was observed for both solutions, the cells proliferated well, and the macroscopic findings of whitening were as follows.
アセボチン ++ トリロバチン +Acebotine ++ Trilobatin +
Claims (1)
R.Br.)の葉、ナツメ(Zizyphus juj
uba M.v.i.R.)の葉又はリンゴ(Malu
s pumila M.v.d.s.)、サクラ(Pr
unus glandulosa T.)、ナシ(Py
rus serotinaRehd.)、又はモモ(P
runus persica Batsch)の幹皮又
は根皮、又はリンゴ(Malus pumilaM.v
.d.s.)の葉、アセビ(Pieris japon
ica D.Don)又はアマシバ(Symploco
s microcalyx)の葉のうち少なくとも1種
以上の成分又はそれらの溶媒抽出物を含有することを特
徴とする皮膚用化粧料組成物。 (2)前記抽出物の溶媒が、水、アルコール又はそれら
の混液である請求項第1項記載の皮膚用化粧料組成物。 (3)前記抽出物が、ギムネマ(Gymnemasyl
vestre R.Br.)の葉についてはギムネマ酸
、ナツメ(Zizyphus jujuba M.v.
i.R.)の葉についてはジィジィフィン、バラ科(R
osaceal)植物の幹皮、根皮又は葉についてはフ
ロリジン又はフロレチン、アセビ(Pieris ja
ponica D.Don)の葉についてはアセボチン
、アマシバ(Symplocosmicrocalyx
)の葉についてはトリロバチンを含有するように調整し
又は加工されたものである請求項第2項記載の皮膚用化
粧料組成物。 (4)ギムネマ酸、ジィジィフィン、フロリジン、フロ
レチン、アセボチン又はトリロバチンから選ばれた1種
又は2種以上を含有することを特徴とする皮膚用化粧料
組成物。[Claims] 1) Gymnema sylvestre
R. Br. ) leaves, jujube (Zizyphus juj
uba M. v. i. R. ) leaves or apple (Malu
s pumila M. v. d. s. ), Sakura (Pr
unus glandulosa T. ), pear (Py
rus serotinaRehd. ), or peach (P
stem bark or root bark of Malus persica Batsch) or apple (Malus pumila M.v
.. d. s. ) leaves, Pieris japon
ica D. Don) or Symploco
A skin cosmetic composition comprising at least one component of the leaves of S. microcalyx or a solvent extract thereof. (2) The skin cosmetic composition according to claim 1, wherein the solvent for the extract is water, alcohol, or a mixture thereof. (3) The extract may contain Gymnemasyl
vestre R. Br. ) for the leaves of gymnemic acid, jujube (Zizyphus jujuba M.v.).
i. R. ) Leaves of Gigifin, Rosaceae (R
phlorizin or phloretin for the stem bark, root bark or leaves of Pieris ja
ponica D. For leaves of Don), acebotine, Symplocos microcalyx
3. The skin cosmetic composition according to claim 2, wherein the leaves of the following are adjusted or processed to contain trilobatin. (4) A skin cosmetic composition containing one or more selected from gymnemic acid, zydyfin, phlorizin, phloretin, acebotin, or trilobatin.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1115796A JP2810107B2 (en) | 1989-05-08 | 1989-05-08 | Cosmetic composition for skin |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1115796A JP2810107B2 (en) | 1989-05-08 | 1989-05-08 | Cosmetic composition for skin |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH02292208A true JPH02292208A (en) | 1990-12-03 |
JP2810107B2 JP2810107B2 (en) | 1998-10-15 |
Family
ID=14671291
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP1115796A Expired - Fee Related JP2810107B2 (en) | 1989-05-08 | 1989-05-08 | Cosmetic composition for skin |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2810107B2 (en) |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0815842A2 (en) * | 1996-07-04 | 1998-01-07 | Mina Safai-Ghomi | Medicaments and cosmetics comprising zizyphus-spina-christi extracts |
KR20010086190A (en) * | 2000-02-11 | 2001-09-10 | 이영준 | Skin Whitening Composition with Gymnema Extract |
WO2006064974A1 (en) * | 2004-12-17 | 2006-06-22 | Shiseido Company, Ltd. | Skin whitening preparation for external use, whitening preparation, whitening method and method of producing skin whitening preparation for external use |
JP2007106712A (en) * | 2005-10-14 | 2007-04-26 | Maruzen Pharmaceut Co Ltd | Skin cosmetic and hair cosmetic |
JP2007269743A (en) * | 2006-03-31 | 2007-10-18 | Naris Cosmetics Co Ltd | Skin care preparation |
US7722901B2 (en) | 2004-01-16 | 2010-05-25 | Cognis Ip Management Gmbh | Uses for the extract of a plant of the family Asclepiadaceae |
JP2011079744A (en) * | 2009-10-02 | 2011-04-21 | Nippon Menaade Keshohin Kk | External preparation for skin |
WO2012050895A1 (en) | 2010-09-28 | 2012-04-19 | Lisa Geng | Methods for treating neurological disorders using nutrient compositions |
JP2012092138A (en) * | 2011-12-27 | 2012-05-17 | Maruzen Pharmaceut Co Ltd | Skin cosmetic and hair cosmetic |
WO2013114394A3 (en) * | 2012-01-09 | 2013-11-07 | Shiromani Gurudwara Prabandhak | A polyherbal composition for skin care |
FR3015284A1 (en) * | 2013-12-24 | 2015-06-26 | Clarins Lab | COSMETIC USE OF A GYMNEMA SYLVESTRE EXTRACT |
CN104997717A (en) * | 2014-04-21 | 2015-10-28 | 大真堂生物科技(北京)有限公司 | Rose composition |
US9931365B2 (en) | 2010-09-28 | 2018-04-03 | Lisa Geng | Methods for treating neurological disorders using nutrient compositions |
US11957725B2 (en) | 2022-04-06 | 2024-04-16 | Lisa Geng | Methods for treating neurological disorders using nutrient compositions |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5993011A (en) * | 1982-11-16 | 1984-05-29 | Ichimaru Fuarukosu Kk | Cosmetic containing extract of jujube fruit |
JPS63230624A (en) * | 1987-03-18 | 1988-09-27 | Earth Chem Corp Ltd | Bath liquid |
JPH02207012A (en) * | 1989-02-03 | 1990-08-16 | Riyuuhoudou Seiyaku Kk | Cosmetic for preventing skin from aging |
-
1989
- 1989-05-08 JP JP1115796A patent/JP2810107B2/en not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5993011A (en) * | 1982-11-16 | 1984-05-29 | Ichimaru Fuarukosu Kk | Cosmetic containing extract of jujube fruit |
JPS63230624A (en) * | 1987-03-18 | 1988-09-27 | Earth Chem Corp Ltd | Bath liquid |
JPH02207012A (en) * | 1989-02-03 | 1990-08-16 | Riyuuhoudou Seiyaku Kk | Cosmetic for preventing skin from aging |
Cited By (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0815842A3 (en) * | 1996-07-04 | 1998-01-28 | Mina Safai-Ghomi | Medicaments and cosmetics comprising zizyphus-spina-christi extracts |
EP0815842A2 (en) * | 1996-07-04 | 1998-01-07 | Mina Safai-Ghomi | Medicaments and cosmetics comprising zizyphus-spina-christi extracts |
KR20010086190A (en) * | 2000-02-11 | 2001-09-10 | 이영준 | Skin Whitening Composition with Gymnema Extract |
US7722901B2 (en) | 2004-01-16 | 2010-05-25 | Cognis Ip Management Gmbh | Uses for the extract of a plant of the family Asclepiadaceae |
WO2006064974A1 (en) * | 2004-12-17 | 2006-06-22 | Shiseido Company, Ltd. | Skin whitening preparation for external use, whitening preparation, whitening method and method of producing skin whitening preparation for external use |
JP2006169188A (en) * | 2004-12-17 | 2006-06-29 | Shiseido Co Ltd | Skin care preparation for whitening, whitening agent, whitening method and method for producing skin care preparation for whitening |
JP2007106712A (en) * | 2005-10-14 | 2007-04-26 | Maruzen Pharmaceut Co Ltd | Skin cosmetic and hair cosmetic |
JP2007269743A (en) * | 2006-03-31 | 2007-10-18 | Naris Cosmetics Co Ltd | Skin care preparation |
JP2011079744A (en) * | 2009-10-02 | 2011-04-21 | Nippon Menaade Keshohin Kk | External preparation for skin |
WO2012050895A1 (en) | 2010-09-28 | 2012-04-19 | Lisa Geng | Methods for treating neurological disorders using nutrient compositions |
US9931365B2 (en) | 2010-09-28 | 2018-04-03 | Lisa Geng | Methods for treating neurological disorders using nutrient compositions |
US11369652B2 (en) | 2010-09-28 | 2022-06-28 | Lisa Geng | Methods for treating neurological disorders using nutrient compositions |
US8962042B2 (en) | 2010-09-28 | 2015-02-24 | Lisa Geng | Methods for treating neurological disorders using nutrient compositions |
US10722546B2 (en) | 2010-09-28 | 2020-07-28 | Lisa Geng | Methods for treating neurological disorders using nutrient compositions |
JP2012092138A (en) * | 2011-12-27 | 2012-05-17 | Maruzen Pharmaceut Co Ltd | Skin cosmetic and hair cosmetic |
US9572766B2 (en) | 2012-01-09 | 2017-02-21 | Shiromani Gurudwara Prabandhak Committee's Guru Nanak Khalsa College | Polyherbal composition for skin care |
WO2013114394A3 (en) * | 2012-01-09 | 2013-11-07 | Shiromani Gurudwara Prabandhak | A polyherbal composition for skin care |
WO2015097601A1 (en) * | 2013-12-24 | 2015-07-02 | Laboratoires Clarins | Cosmetic use of an extract of gymnema sylvestre |
RU2682963C2 (en) * | 2013-12-24 | 2019-03-25 | Лаборатуар Кларанс | Cosmetic use of extract of gymnema sylvestre |
FR3015284A1 (en) * | 2013-12-24 | 2015-06-26 | Clarins Lab | COSMETIC USE OF A GYMNEMA SYLVESTRE EXTRACT |
CN104997717A (en) * | 2014-04-21 | 2015-10-28 | 大真堂生物科技(北京)有限公司 | Rose composition |
US11957725B2 (en) | 2022-04-06 | 2024-04-16 | Lisa Geng | Methods for treating neurological disorders using nutrient compositions |
Also Published As
Publication number | Publication date |
---|---|
JP2810107B2 (en) | 1998-10-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8101214B2 (en) | Composition for skin external application containing complex of herbal extracts | |
JP5683134B2 (en) | Topical skin preparation | |
CA2485403C (en) | Use of purslane to treat facial wrinkles | |
KR101425031B1 (en) | Cosmetic composition for anti-irritation and skin moisturization containing Citrus junos Siebold seed oil and Mangifera Indica seed oil | |
KR101387308B1 (en) | Skin whitening composition by using of dendropanax morbifera ferment extract | |
JP2000169383A (en) | Antiallergic agent | |
JP2011246353A5 (en) | ||
JPH02292208A (en) | Skin cosmetic composition | |
KR100762965B1 (en) | Preparation methods of Panax ginseng extract increased contents of physiologically active substances Rb1, Rb2, Rc and Rd | |
JP2008525462A (en) | Methods and compositions for reducing the appearance of wrinkles | |
JP4495406B2 (en) | Sendangusa plant extract-containing composition | |
JP2010520232A (en) | External preparation composition containing ginseng extract and its use as a skin moisturizing cosmetic | |
JP2003089658A (en) | Skin lotion and food excellent in anti-itchiness effectiveness | |
JP2588723B2 (en) | Hair cosmetics | |
JPS5916816A (en) | Composition for external use | |
KR20210056984A (en) | Composition for improving skin | |
JPH10158181A (en) | Lipolysis promoter and skin cosmetic for weight reduction | |
JPH0138762B2 (en) | ||
KR100639408B1 (en) | Cosmetic composition comprising the extract of Bambusae Folium showing inhibitory effect and whitening effect on UV-induced skin damage | |
JPH10152444A (en) | Inhibitor of maillard reaction and cosmetic | |
KR20010028372A (en) | Cosmetic material composition for skin whitening | |
JPH0310609B2 (en) | ||
JPH11193243A (en) | Skin preparation for external use | |
KR100789635B1 (en) | Skin Whitening Cosmetic containing a herb extract with inhibitory activity of melanin formation | |
JPH02207012A (en) | Cosmetic for preventing skin from aging |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
LAPS | Cancellation because of no payment of annual fees |